Hyperthermic intraperitoneal chemotherapy in ovarian cancer: experience from a tertiary hospital in northern Taiwan. Asian society of gynecologic oncology biannual meeting, December 2017 Chen WC, Qiu JT, Lai CH, Huang HJ, Lin CT, Chen MY, et al.
Late recurrence of cervical cancer: outcomes and prognostic factors. European Society of Gynecology Oncology biannual meeting, November 2017 Chen WC, Qiu JT, Lai CH, Huang HJ, Lin CT, Chen MY, et al.
Dose-dense chemotherapy with weekly paclitaxel & 3-weekly carboplatin for recurrent ovarian cancer: Experience of a tertiary hospital in Taiwan and literature review. Taiwan Association of Obstetric Gynecology annual meeting, March 2016 Chen WC, Qiu JT, Lai CH, Huang HJ, Lin CT, Chen MY, et al.
ntraperitoneal administration of Bevacizumab in malignant ascites of ovarian cancer. Taiwan Association of Obstetric Gynecology annual meeting, March 2016 Chen WC, Qiu JT, Lai CH, Huang HJ, Lin CT, Chen MY, et al.
Outcomes and prognoses of patients with ovarian cancer using bevacizumab: 6-year experience in a tertiary care hospital of northern Taiwan. PLoS One 2017;12:e0175703. Chen WC, Qiu JT, Lai CH, Huang HJ, Lin CT, Chen MY, et al.
